Exchange: NASDAQ·Updated 04:10 PM EDT
BOLT logo

BOLT Bolt Biotherapeutics Inc

$4.09
$0.165
(4.33%)
Today
Closed $3.98
$0.11
(2.76%)
After Hours
Reported EarningsAug 11
Mkt Cap$7.35M
Vol4,958.00

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.
34

Bearish Sentiment

How do you feel about BOLT?

Advertisement|Remove ads.